NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
127 hedge funds and large institutions have $935M invested in NxStage Medical Inc. in 2015 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 55 increasing their positions, 42 reducing their positions, and 26 closing their positions.
716% more call options, than puts
Call options by funds: $7.52M | Put options by funds: $922K
31% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 42
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
12% more capital invested
Capital invested by funds: $837M → $935M (+$98M)
9% less funds holding
Funds holding: 139 → 127 (-12)
42% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$21M |
| 2 |
DM
Deerfield Management
New York
|
+$8.74M |
| 3 |
RIM
RS Investment Management
San Francisco,
California
|
+$7.8M |
| 4 |
Bank of New York Mellon
New York
|
+$6.22M |
| 5 |
Millennium Management
New York
|
+$5.27M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
-$18.6M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$16M |
| 3 |
William Blair & Company
Chicago,
Illinois
|
-$10.1M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$7.37M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$4.43M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PCM
151
Prelude Capital Management
New York
| – | -$16K | -1,150 | Closed |
|
152
Citigroup
New York
| – | -$14.1K | -877 | -99% |
|
|
HNB
153
Huntington National Bank
Columbus,
Ohio
| – | -$7K | -500 | Closed |
|
NXTM Hedge Fund Activity: Q3 2015 in Review
127 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q3 2015, worth a combined $935M — up 12% from $837M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of NXTM and 15 opened new positions — a net loss of 11 holders — while 42 trimmed existing stakes and 55 added.
The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $21M. The largest seller was Chartwell Investment Partners, cutting an estimated $18.6M.
- 127 institutional investors held NxStage Medical Inc. (NXTM) as of Q3 2015, down from 139 in Q2 2015.
- Funds reported $935M of NxStage Medical Inc. stock for Q3 2015, up 12% quarter-over-quarter.
- 15 funds opened new NxStage Medical Inc. positions in Q3 2015 and 26 closed out, a net change of -11 holders.
- The largest NxStage Medical Inc. buyer in Q3 2015 was Gilder Gagnon Howe & Co, an estimated $21M added.
- The largest NxStage Medical Inc. seller in Q3 2015 was Chartwell Investment Partners, an estimated $18.6M sold.
Based on aggregated 13F filings for Q3 2015.